Segment Information - Schedule of Revenue by Different Product Lines (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2017 |
Jun. 30, 2016 |
Jun. 30, 2017 |
Jun. 30, 2016 |
|
Product Revenue Total | $ 1,072,861 | $ 956,486 | $ 1,740,111 | $ 1,694,510 |
License Fees | ||||
Total Revenue | 1,072,861 | 956,486 | 1,740,111 | 1,694,510 |
MicroParticle Calalyzed Biosensor ("MPC") [Member] | ||||
Product Revenue Total | 69,848 | 44,918 | 155,507 | 109,702 |
Particle ImmunoFiltration Assay ("PIFA") [Member] | ||||
Product Revenue Total | 426,747 | 879,081 | 987,668 | 1,514,256 |
Other [Member] | ||||
Product Revenue Total | $ 576,266 | $ 32,487 | $ 596,936 | $ 70,552 |
X | ||||||||||
- Definition Revenue from multiple-deliverable arrangements that include licensing fees and services revenue. Licensing revenue is consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. Services revenue may be derived by providing other, nonspecified, services during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|